Скачать или смотреть 1 Year Access & Adoption of Epinephrine Nasal Spray

If you missed it, HCPLive put together a feature for the 1-year anniversary of the FDA approval of epinephrine nasal spray (neffy) for severe allergic reactions. In the feature, Matthew Greenhawt, MD, MBA, CMO of Asthma and Allergy Foundation of America, provided insight into the access, adoption, and concerns related to this treatment.

Here in this solo interview, Greenhawt shared how epinephrine nasal spray has impacted the anaphylaxis management landscape.

Check out the full feature on epinephrine nasal spray, with insights from Greenhawt and experts Brian Schroer, MD (Cleveland Clinic), Colleen Kraft, MD, MBA (Children’s Hospital Los Angeles), Ryan Haumschild, PharmD, MS, MBA (Emory Healthcare), and Thomas Casale, MD (University of South Florida) here: https://www.hcplive.com/view/one-year...